HDAC4 and chronic kidney disease: Here, we investigated the function and mechanism of HDAC4 in ischemia–reperfusion (IR)–induced AKI–CKD progression using Tasquinimod, a highly selective HDAC4 inhibitor, and conditional tubular HDAC4 knockout mice.